Creo Medical Group (CREO)

Sector:

Health Care

Index:

FTSE AIM All-Share

11.08p
   
  • Change Today:
    -0.17p
  • 52 Week High: 36.50p
  • 52 Week Low: 9.55p
  • Currency: UK Pounds
  • Shares Issued: 412.47m
  • Volume: 1,115,077
  • Market Cap: £45.72m
  • Beta: 0.00

CREO Overview

Creo Medical was founded in 2003 as MicroOncology Ltd by Professor Chris Hancock, initially to target the treatment of cancers through use of high frequency microwave energy and dynamic matching techniques.

1 Day Chart

1 Day Chart

6 Month Chart

6 Month Chart

Financials

Latest F'cast
Div Yield 0.0% 0.0%
Div Cover n/a n/a
Op Mrgn -80.5% -73.3%
ROCE n/a  
Latest F'cast
P/E n/a n/a
PEG n/a n/a
Pr/Revenue 1.5 1.3
Pr/Book 0.8  
Latest F'cast
Revenue 13.2% 1.4%
PBT n/a n/a
EPS n/a n/a
DPS n/a n/a

CREO Fundamentals

Year Ending Revenue (£m) Pre-tax (£m) EPS P/E PEG EPS Grth. Div Yield
31-Dec-19 0.01 (18.62) (12.54)p n/a n/a n/a n/a 0.0%
31-Dec-20 9.43 (23.46) (12.54)p n/a n/a n/a n/a 0.0%
31-Dec-21 25.16 (30.34) (14.48)p n/a n/a n/a n/a 0.0%
31-Dec-22 27.20 (30.90) (14.48)p n/a n/a n/a n/a 0.0%
31-Dec-23 30.80 (24.50) (7.00)p n/a n/a n/a n/a 0.0%

a. Based on UK GAAP presentation of accounts - includes discontinued activities

CREO Forecasts

Year Ending Revenue (£m) Pre-tax (£m) EPS P/E PEG EPS Grth. Div Yield
31-Dec-24 31.23 (22.89) (5.96)p n/a n/a n/a n/a 0.0%
31-Dec-25 27.47 (9.10) (3.94)p n/a n/a n/a n/a 0.0%
31-Dec-26 36.58 (12.03) (1.88)p n/a n/a n/a n/a 0.0%

Copyright © 2025 FactSet Research Systems Inc. All rights reserved.

CREO Company Announcements

Notice of Results 15-Apr-2025 14:00 RNS
Holding(s) in Company 01-Apr-2025 09:34 RNS
Holding(s) in Company 31-Mar-2025 12:17 RNS

Latest CREO Director Deals

No deals were found in the last 28 days.

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: Above ratios are on a 'per annum' basis, adjusted for corporate actions and based on the fundamentals of the primary listed security.

Note 3: Under IFRS, all figures are based on 'Continuing' operations unless otherwise stated.

Note 4: In the case of dual listed securities, broker recommendations and forecasts relate to the primary listing.

Note 5: Forecast figures based on normalised accounts.

 

CREO Market Data

Currency UK Pounds
Share Price 11.08p
Change Today -0.17p
% Change -1.48 %
52 Week High 36.50p
52 Week Low 9.55p
Volume 1,115,077
Shares Issued 412.47m
Market Cap £45.72m
Beta 0.00

CREO Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
40.75% above the market average40.75% above the market average40.75% above the market average40.75% above the market average40.75% above the market average
11.76% above the sector average11.76% above the sector average11.76% above the sector average11.76% above the sector average11.76% above the sector average
Price Trend
83.8% below the market average83.8% below the market average83.8% below the market average83.8% below the market average83.8% below the market average
62.16% below the sector average62.16% below the sector average62.16% below the sector average62.16% below the sector average62.16% below the sector average
Income Not Available
Growth
28.01% above the market average28.01% above the market average28.01% above the market average28.01% above the market average28.01% above the market average
31.43% above the sector average31.43% above the sector average31.43% above the sector average31.43% above the sector average31.43% above the sector average

What The Brokers Say

Strong Buy 1
Buy 0
Neutral 0
Sell 0
Strong Sell 0
Total 1
strong_buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

CREO Dividends

No dividends found

Trades for 30-Apr-2025

Time Volume / Share Price
14:29 4,400 @ 11.17p
14:09 1,242 @ 11.09p
14:06 46,257 @ 10.99p
14:03 85,034 @ 10.96p
13:26 20,000 @ 10.80p

CREO Key Personnel

CEO Craig Jonathan Gulliford
CFO Richard John Rees

Top of Page